Status:
COMPLETED
Troponin to Detect Major Cardiovasculaire Advserse Events on Immune Checkpoint Inhibitors
Lead Sponsor:
Institut Mutualiste Montsouris
Collaborating Sponsors:
Institut Curie
Conditions:
Cancer
Immune Checkpoint Inhibitor
Eligibility:
All Genders
18+ years
Brief Summary
Recent guidelines suggest the use of troponin to detect immnune related cardiovascular advserse events in patients treated by immune checkpoint inhibitors for cancer. However, there is no proof that ...
Detailed Description
Retrospective two-center study comparing two groups of patients on immune checkpoint inhibitors: * Group 1: active surveillance by serial troponin measures not prompted by cardiovascular symptoms ; *...
Eligibility Criteria
Inclusion
- All solid cancer patients treated by immune checkpoint inhibitors 2017-2022
Exclusion
- Patients enrolled in an invterventional study (e.g., pharma trial)
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06007274
Start Date
July 1 2023
End Date
July 1 2024
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Mutualiste Montsouris
Paris, France, 75014